Familial risks of ovarian cancer by age at diagnosis, proband type and histology
- PMID: 30281663
- PMCID: PMC6169923
- DOI: 10.1371/journal.pone.0205000
"V体育官网" Familial risks of ovarian cancer by age at diagnosis, proband type and histology
V体育ios版 - Erratum in
-
Correction: Familial risks of ovarian cancer by age at diagnosis, proband type and histology.PLoS One. 2018 Oct 26;13(10):e0206721. doi: 10.1371/journal.pone.0206721. eCollection 2018. PLoS One. 2018. PMID: 30365548 Free PMC article.
Abstract
Ovarian cancer is a heterogeneous disease. Data regarding familial risks for specific proband, age at diagnosis and histology are limited. Such data can assist genetic counseling and help elucidate etiologic differences among various histologic types of ovarian malignancies. By using the Swedish Family-Cancer Database, we calculated relative risks (RRs) for detailed family histories using a two-way comparison, which implied e. g. estimation of RRs for overall ovarian cancer when family history was histology-specific ovarian cancer, and conversely, RRs for histology-specific ovarian cancer when family history was overall ovarian cancer. In families of only mother, only sisters or both mother and sisters diagnosed with ovarian cancer, cancer risks for ovary were 2. 40, 2. 59 and 10 VSports手机版. 40, respectively; and were higher for cases diagnosed before the age of 50 years. All histological types showed a familial risk in two-way analyses, except mucinous and sex cord-stromal tumors. RRs for concordant histology were found for serous (2. 47), endometrioid (3. 59) and mucinous ovarian cancers (6. 91). Concordant familial risks were highest for mucinous cancer; for others, some discordant associations, such as endometrioid-undifferentiated (9. 27) and serous-undifferentiated (4. 80), showed the highest RRs. Familial risks are high for early-onset patients and for those with multiple affected relatives. Sharing of different histological types of ovarian cancer is likely an indication of the complexity of the underlying mechanisms. .
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
V体育ios版 - References
-
- Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. AACR; 2017. - PubMed
-
- CentreforEpidemiology. Cancer incidence in Sweden 2012. Stockholm: The National Board of Health and Welfare, 2013.
-
- Glance A. Ovarian cancer: an overview. Am Fam Physician. 2009;80(6):609–16. - PubMed
-
- Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23257 women with ovarian cancer and 87303 controls. The Lancet. 2008;371(9609):303–14. 10.1016/S0140-6736(08)60167-1 - DOI - PubMed
"VSports最新版本" Publication types
- "VSports注册入口" Actions
MeSH terms
- "VSports注册入口" Actions
- Actions (V体育安卓版)
- Actions (VSports手机版)
- "V体育ios版" Actions
- "VSports最新版本" Actions
- Actions (V体育安卓版)